BSc (Hons), MSc, PhD
Máiréid joined the Oxford Vaccine Group as a Postdoctoral Immunologist under Professor Teresa Lambe in September 2021. She joins the ongoing work on COVID-19 clinical trials and will be pursuing exploratory T cell research in the context of COVID-19 vaccination.
Máiréid previously completed a BSc in Immunology at the University of Glasgow and an Immunology of Infectious Diseases MSc at the London School of Hygiene and Tropical Medicine. She completed her PhD at the University of Hong Kong, under the supervision of Professor Leo Poon and Dr Sophie Valkenburg. Previous PhD work investigated the effect of immune pressure elicited by next generation influenza vaccines on the IAV genome.
Her primary research interests include viral respiratory diseases, vaccine development, T cells and immune imprinting.
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Mentzer AJ. et al, (2023), Nat Med, 29, 147 - 157
Early vaccine mediated strain specific cytokine imbalance induces mild immunopathology during influenza infection.
Bull MB. et al, (2022), Immunol Cell Biol
Next-generation T cell–activating vaccination increases influenza virus mutation prevalence
Bull MB. et al, (2022), Science Advances, 8
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.
Mok CKP. et al, (2022), Respirology, 27, 301 - 310
Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread.
Bull MB. et al, (2021), Viruses, 13